Tiziana Life Sciences Statistics
Total Valuation
TLSA has a market cap or net worth of $78.47 million. The enterprise value is $60.71 million.
| Market Cap | 78.47M |
| Enterprise Value | 60.71M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TLSA has 100.59 million shares outstanding.
| Shares Outstanding | 100.59M |
| Owned by Insiders (%) | 38.04% |
| Owned by Institutions (%) | 0.78% |
| Float | 61.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.01 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.64 |
| Quick Ratio | 3.01 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,198.57 |
Financial Efficiency
Return on equity (ROE) is -50.60% and return on invested capital (ROIC) is -73.16%.
| Return on Equity (ROE) | -50.60% |
| Return on Assets (ROA) | -40.90% |
| Return on Capital (ROIC) | -73.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.71M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.15% in the last 52 weeks. The beta is 0.23, so TLSA's price volatility has been lower than the market average.
| Beta (1Y) | 0.23 |
| 52-Week Price Change | -17.15% |
| 50-Day Moving Average | 0.52 |
| 200-Day Moving Average | 0.61 |
| Relative Strength Index (RSI) | 71.23 |
| Average Volume (30 Days) | 169,495 |
Short Selling Information
| Short Interest | 257,778 |
| Short Previous Month | 322,155 |
| Short % of Shares Out | 0.42% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.98 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.59M |
| Pretax Income | -15.40M |
| Net Income | -15.40M |
| EBITDA | -15.34M |
| EBIT | -15.39M |
| Earnings Per Share (EPS) | -$0.15 |
Balance Sheet
The company has $18.12 million in cash and $365,000 in debt, giving a net cash position of $17.76 million or $0.18 per share.
| Cash & Cash Equivalents | 18.12M |
| Total Debt | 365,000 |
| Net Cash | 17.76M |
| Net Cash Per Share | $0.18 |
| Equity / Book Value | 19.57M |
| Book Value Per Share | 0.19 |
| Working Capital | 17.62M |
Cash Flow
| Operating Cash Flow | -19.62M |
| Capital Expenditures | n/a |
| Free Cash Flow | -19.62M |
| FCF Per Share | -$0.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TLSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.10% |
| Shareholder Yield | -5.10% |
| Earnings Yield | -19.62% |
| FCF Yield | -25.00% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 31, 2020. It was a forward split with a ratio of 2499:1000.
| Last Split Date | Jul 31, 2020 |
| Split Type | Forward |
| Split Ratio | 2499:1000 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |